- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02374775
Exploring the MEchanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and computationaL Fluid Dynamic (EMERALD)
Exploring the MEchanism of Plaque Rupture in Acute Coronary Syndrome Using Coronary CT Angiography and computationaL Fluid Dynamics (EMERALD)
Study Overview
Status
Detailed Description
The mechanisms of plaque rupture have not been fully understood. Hemodynamic forces acting on the plaque, plaque vulnerability, and the interaction between two factors might be the most important mechanism to explain various feature and location of plaque rupture.
The objectives of the study are
- To explore the interaction between hemodynamic forces measured by computational fluid dynamics (CFD) analysis and plaque vulnerability in culprit lesion of subsequent clinical events.
- To build rupture risk scoring system, incorporating independent predictor for plaque rupture.
The EMERALD trial is a multinational and multicenter study. The patients presented with AMI/plaque rupture and had underwent coronary CT angiography from 1 month to 2 year prior to the event will be retrospectively searched. Plaques in the non-culprit vessels will be regarded as internal control to the ruptured plaque in the culprit vessel.
The enrollment criteria will be
- Patients who presented with acute coronary syndrome with cardiac enzyme elevation (AMI)/plaque rupture.
- Among those patients, the patients who underwent coronary CT angiography, regardless of the reason prior to the acute event will be searched. The time limit of coronary CT angiography will be 1 month ~ 2 year prior to the event.
The Computational Fluids Dynamics (CFD) and Fluid-Structural Interaction (FSI) simulation will be performed to comprehensively evaluate the total plaque forces and their interaction with the plaque.
The comparison groups will be defined as follows; The plaque in the culprit vessel of AMI will be defined the Group A. The plaque in the non-culprit vessel of AMI will be defined as internal control, Group B.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Seoul, Korea, Republic of, 135-710
- Samsung Medical Center
-
Seoul, Korea, Republic of, 110-744
- Seoul National University Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients who experienced acute myocardial infarction from 2010-2014 whose diagnosis have confirmed by invasive coronary angiography with or without IVUS or OCT evaluation, and who underwent coronary CT angiography from 1 month to 2 year prior to the acute myocardial infarction event.
Exclusion Criteria:
- Acute coronary syndrome without cardiac enzyme elevation (unstable angina)
- Patients who did not underwent coronary CT angiography, 1 month to 2 years prior to the acute myocardial infarction
- Poor CT images (unable to reconstruct 3 dimensional coronary artery model)
- The time period between coronary CT angiography and acute myocardial infarction exceed more than 2 years
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Group A (Culprit lesion)
The plaque in the culprit vessel of acute myocardial infarction will be defined the Group A.
|
Group B (Non-culprit lesion)
The plaque in the non-culprit vessel of acute myocardial infarction will be defined as internal control, Group B.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The difference of area under curve between prediction model with adverse plaque characteristics and model with adverse plaque characteristics and hemodynamic forces
Time Frame: from 1 month - 2 year
|
Model 1 : percent diameter stenosis + adverse plaque characteristics defined by CT angiography Model 2 : percent diameter stenosis + adverse plaque characteristics defined by CT angiography + Hemodynamic forces defined by computational fluid dynamics
|
from 1 month - 2 year
|
The difference of net reclassification index between prediction model with adverse plaque characteristics and model with adverse plaque characteristics and hemodynamic forces
Time Frame: from 1 month - 2 year
|
Model 1 : percent diameter stenosis + adverse plaque characteristics defined by CT angiography Model 2 : percent diameter stenosis + adverse plaque characteristics defined by CT angiography + Hemodynamic forces defined by computational fluid dynamics
|
from 1 month - 2 year
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The best cut-off value of axial plaque stress to induce plaque rupture.
Time Frame: from 1 month - 2 year
|
from 1 month - 2 year
|
The threshold of the plaque vulnerability (Housefiled unit of the plaque on CT) to induce rupture.
Time Frame: from 1 month - 2 year
|
from 1 month - 2 year
|
The independent predictors for the plaque rupture using generalized estimating equation, and the c-index of the predicting models.
Time Frame: from 1 month - 2 year
|
from 1 month - 2 year
|
The validity of rupture risk score which constructed from the predicting model.
Time Frame: from 1 month - 2 year
|
from 1 month - 2 year
|
The differences in other hemodynamic parameters for example, pressure gradient, delta pressure, FFRCT, average and peak wall shear stress between Group A and Group B.
Time Frame: from 1 month - 2 year
|
from 1 month - 2 year
|
The association between axial plaque stress and the parameter reflecting plaque geometry (radius gradient).
Time Frame: from 1 month - 2 year
|
from 1 month - 2 year
|
The differences in axial plaque stress between Group A and Group B
Time Frame: from 1 month - 2 year
|
from 1 month - 2 year
|
The differences in plaque vulnerability (Housefiled unit of the plaque on CT) between Group A and Group B
Time Frame: from 1 month - 2 year
|
from 1 month - 2 year
|
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Joo Myung Lee, MD, MPH, Samsung Medical Center
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NCT02374775
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myocardial Infarction
-
University Medical Centre LjubljanaCompletedCardiac Arrest | Postresuscitation Syndrome | Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)Slovenia
-
Fundacio Privada Mon Clinic BarcelonaMiracor Medical SANot yet recruiting
-
Azienda ULSS 5 PolesanaUniversity of PadovaUnknownMyocardial Infarction, Acute | ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Italy
-
Stiftung Institut fuer HerzinfarktforschungGlaxoSmithKline; University Hospital Muenster; Klinikum NürnbergCompletedMyocardial Infarction | ST-Elevation Myocardial Infarction | Non-ST-Elevation Myocardial InfarctionGermany
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Boston Scientific CorporationActive, not recruitingST Elevation Myocardial Infarction | Non ST Elevation Myocardial InfarctionCanada
-
Bispebjerg HospitalOdense University Hospital; Zealand University Hospital; Hvidovre University... and other collaboratorsRecruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Denmark
-
Barts & The London NHS TrustUniversity College, London; Queen Mary University of LondonCompletedAcute Myocardial InfarctionSwitzerland, Denmark, United Kingdom
-
University of LeedsUniversity College, LondonCompletedST-elevation Myocardial Infarction | Non ST-elevation Myocardial Infarction
-
Miracor Medical SARecruitingInferior Wall Myocardial Infarction | STEMI - ST Elevation Myocardial InfarctionFrance, United Kingdom, Latvia, Switzerland, Denmark
-
Miracor Medical SAWithdrawnAnterior Wall Myocardial Infarction | STEMI - ST Elevation Myocardial Infarction